CORD-19:0036b28fddf7e93da0970303672934ea2f9944e7 / 296011-296250
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2387","span":{"begin":0,"end":239},"obj":"Sentence"},{"id":"T89462","span":{"begin":0,"end":239},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This study shows that a small proportion (9%) of dogs receiving vincristine, initially as a sole agent, but as part of a chemotherapy protocol for lymphoma, developed a significant neutropenia within one week of vincristine administration."}
CORD-19-PD-MONDO
{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1222","span":{"begin":147,"end":155},"obj":"Disease"},{"id":"T1223","span":{"begin":181,"end":192},"obj":"Disease"},{"id":"T3982","span":{"begin":147,"end":155},"obj":"Disease"},{"id":"T79946","span":{"begin":181,"end":192},"obj":"Disease"}],"attributes":[{"id":"A1222","pred":"mondo_id","subj":"T1222","obj":"http://purl.obolibrary.org/obo/MONDO_0005062"},{"id":"A1223","pred":"mondo_id","subj":"T1223","obj":"http://purl.obolibrary.org/obo/MONDO_0001475"},{"id":"A30789","pred":"mondo_id","subj":"T3982","obj":"http://purl.obolibrary.org/obo/MONDO_0005062"},{"id":"A83025","pred":"mondo_id","subj":"T79946","obj":"http://purl.obolibrary.org/obo/MONDO_0001475"}],"text":"This study shows that a small proportion (9%) of dogs receiving vincristine, initially as a sole agent, but as part of a chemotherapy protocol for lymphoma, developed a significant neutropenia within one week of vincristine administration."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T784","span":{"begin":147,"end":155},"obj":"Phenotype"},{"id":"T785","span":{"begin":181,"end":192},"obj":"Phenotype"}],"attributes":[{"id":"A784","pred":"hp_id","subj":"T784","obj":"http://purl.obolibrary.org/obo/HP_0002665"},{"id":"A785","pred":"hp_id","subj":"T785","obj":"http://purl.obolibrary.org/obo/HP_0001875"}],"text":"This study shows that a small proportion (9%) of dogs receiving vincristine, initially as a sole agent, but as part of a chemotherapy protocol for lymphoma, developed a significant neutropenia within one week of vincristine administration."}